For the non-CKD group, although mortality increased when the Hb level was below the 12–13 g/dL interval (the reference interval), a higher Hb level above this interval was not significantly associated with increased mortality (Fig. 4a). This evidence concerns the gene GSTM1 and chronic kidney disease.